Motegrity is here to support
your patients

If you're looking for information on patient savings or an insurance
coverage tool, you've come to the right place. Have a look below at the
various savings and support programs that Motegrity has to offer.

If you're looking for information on patient savings or an insurance
coverage tool, you've come to the right place. Have a look below at the
various savings and support programs that Motegrity has to offer.

Insurance Access for Patients

Wondering which insurance plans in your area cover Motegrity?
Use this Patient Access Coverage Tool (PACT) to search for 
eligibility on a variety of top plans nationwide.

Maintain their momentum

available in a 90-day supply

Saving card

With the Motegrity savings card, eligible patients may
pay as little as $15 per 30-day or 90-day prescription.*

A 90 day prescription means fewer pharmacy visits to help
your patients maintain their momentum between office visits.

* Up to $90 max benefit per 30-day prescription; $325 max benefit per 90-day prescription. Terms and conditions apply. Click here for more details.

Saving card

* Up to $90 max benefit per 30-day prescription; $325 max benefit per 90-day prescription. Terms and conditions apply. Click here for more details.

Did you know?

Patients can add the Motegrity Savings Card to the Mobile Wallet on their phone and use it at the pharmacy.

Automatic additional savings
for patients at the pharmacy

Eligible, commercially insured patients can receive up to $200
off their co-pay at participating pharmacies through the
Motegrity eVoucher program.

Not all pharmacies participate.

Pill bottle with dollar sign

Interested in receiving
samples of Motegrity?

If you're looking to offer your patients a trial,
order a 7-day sample today.
Click the link below to get started.

Sample box of Motegrity® (prucalopride) tablets for patients

More Information for your Patients

Download our Motegrity Patient Brochure where you'll find useful
information to give your patients about our CIC treatment option

IMPORTANT SAFETY INFORMATION

Contraindications

  • Hypersensitivity to Motegrity. Reactions including dyspnea, rash, pruritus, urticaria, and facial edema have been observed
  • Intestinal perforation or obstruction due to structural or functional disorder of the gut wall, obstructive ileus, severe inflammatory conditions of the intestinal tract such as Crohn’s disease, ulcerative colitis, and toxic megacolon/megarectum

Warnings and Precautions

Suicidal Ideation and Behavior: In clinical trials, suicides, suicide attempts and suicidal ideation have been reported. Postmarketing cases of suicidal ideation and behavior as well as self-injurious ideation and new onset or worsening of depression have been reported within the first few weeks of starting Motegrity. A causal association between treatment with Motegrity and an increased risk of suicidal ideation and behavior has not been established. Monitor patients for new onset or worsening of depression and emergence of suicidal thoughts and behavior. Instruct patients to discontinue Motegrity immediately and contact their healthcare provider if they experience any of these symptoms.

Adverse Reactions

Most common adverse reactions (≥2%) are headache, abdominal pain, nausea, diarrhea, abdominal distension, dizziness, vomiting, flatulence, and fatigue.

Use in Specific Populations

  • Lactation: Motegrity is present in breast milk. Consider risks and benefits of breastfeeding
  • Pediatric: Safety and effectiveness in pediatric patients have not been established
  • Renal Impairment: A decreased dosage is recommended in patients with severe renal impairment. Avoid Motegrity in patients with end-stage renal disease requiring dialysis

INDICATION

Motegrity is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.

Please click here for full Prescribing Information.